1. Home
  2. TAK vs SNOW Comparison

TAK vs SNOW Comparison

Compare TAK & SNOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAK
  • SNOW
  • Stock Information
  • Founded
  • TAK 1781
  • SNOW 2012
  • Country
  • TAK Japan
  • SNOW United States
  • Employees
  • TAK N/A
  • SNOW N/A
  • Industry
  • TAK Biotechnology: Pharmaceutical Preparations
  • SNOW Computer Software: Prepackaged Software
  • Sector
  • TAK Health Care
  • SNOW Technology
  • Exchange
  • TAK Nasdaq
  • SNOW Nasdaq
  • Market Cap
  • TAK 44.4B
  • SNOW 48.3B
  • IPO Year
  • TAK N/A
  • SNOW 2020
  • Fundamental
  • Price
  • TAK $15.03
  • SNOW $205.67
  • Analyst Decision
  • TAK
  • SNOW Buy
  • Analyst Count
  • TAK 0
  • SNOW 43
  • Target Price
  • TAK N/A
  • SNOW $210.46
  • AVG Volume (30 Days)
  • TAK 2.2M
  • SNOW 5.9M
  • Earning Date
  • TAK 05-08-2025
  • SNOW 05-21-2025
  • Dividend Yield
  • TAK 3.92%
  • SNOW N/A
  • EPS Growth
  • TAK N/A
  • SNOW N/A
  • EPS
  • TAK 0.45
  • SNOW N/A
  • Revenue
  • TAK $30,595,075,281.00
  • SNOW $3,839,761,000.00
  • Revenue This Year
  • TAK $1.01
  • SNOW $25.66
  • Revenue Next Year
  • TAK $1.04
  • SNOW $22.49
  • P/E Ratio
  • TAK $64.83
  • SNOW N/A
  • Revenue Growth
  • TAK 7.45
  • SNOW 27.50
  • 52 Week Low
  • TAK $12.58
  • SNOW $107.13
  • 52 Week High
  • TAK $15.43
  • SNOW $209.80
  • Technical
  • Relative Strength Index (RSI)
  • TAK 60.23
  • SNOW 74.23
  • Support Level
  • TAK $14.51
  • SNOW $178.91
  • Resistance Level
  • TAK $14.75
  • SNOW $209.80
  • Average True Range (ATR)
  • TAK 0.21
  • SNOW 5.29
  • MACD
  • TAK 0.09
  • SNOW 1.78
  • Stochastic Oscillator
  • TAK 99.66
  • SNOW 87.15

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

About SNOW Snowflake Inc.

Founded in 2012, Snowflake is a fully managed platform that consolidates data hosted on different public clouds for centralized analytics and governance. Snowflake's cloud-native architecture allows users to independently scale the compute and storage layers, providing customers with optimized performance at lower costs. The company's data lake and data warehouse products support a variety of use cases, including business analytics, data engineering, and artificial intelligence. Snowflake is widely used by Fortune 2000 companies in financial services, media, and retail sectors.

Share on Social Networks: